57894-0503
Darzalex Faspro
Daratumumab and hyaluronidase-fihj (human recombinant)
INJECTION
Subcutaneous
DARATUMUMAB
1800.0
mg/15mL

HISTIDINE
4.9
mg/15mL

HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
18.4
mg/15mL

HYALURONIDASE (HUMAN RECOMBINANT)
30000.0
U/15mL

METHIONINE
13.5
mg/15mL

POLYSORBATE 20
6.0
mg/15mL

SORBITOL
735.1
mg/15mL
57894-0503-01
1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01) > 15 mL in 1 VIAL, SINGLE-DOSE
May 1, 2020
Immunotherapy
Monoclonal Antibody
CD38
 
In Use